China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

Yang Huang, Head of China Healthcare Research at J.

P.

Morgan, speaks with BioSpectrum Asia about the resurgence of investor confidence in Chinese healthcare, record out-licensing activity, the rise of .